Axillary surgery in early breast cancer: real-world analysis of the INSEMA-trial at three certified university breast cancer centers in Germany regarding the omission of sentinel lymph node biopsy
While omission of sentinel lymph node biopsy appears safe in selected patients, our real-world data suggest that axillary staging retains clinical relevance for guiding personalized treatment, unless other prognostic tests like gene expression profiles are used.
Authors
- Mohamed Elessawy (ORCID: https://orcid.org/0000-0002-2901-396X)
- Marion van Mackelenbergh (ORCID: https://orcid.org/0000-0002-1084-5897)
- A. Rambow (ORCID: https://orcid.org/0009-0005-4972-0177)
- Nikolas Tauber (ORCID: https://orcid.org/0009-0001-4592-2151)
- Franziska Fick
- Malgorzata Banys-Paluchowski (ORCID: https://orcid.org/0000-0002-2374-9482)
- Fabian Kohls
- Achim Rody (ORCID: https://orcid.org/0000-0001-5904-0486)
- Natalia Krawczyk (ORCID: https://orcid.org/0000-0002-6261-2104)
- Karl Werner Fritz Schäfer
- Lisa Steinhilper
- Huy Duc Le (ORCID: https://orcid.org/0000-0003-1003-0839)
- I. Grande-Nagel
- Volkmar Mueller (ORCID: https://orcid.org/0000-0003-4231-7906)
- Nicolaì Maass (ORCID: https://orcid.org/0000-0002-1430-4676)
- Barbara Schmalfeldt
- Lisbeth Hilmer
- Clara Gasthaus
Institutions
- Universität Hamburg (DE)
- Düsseldorf University Hospital (DE)
- Universitäres Kinderwunschzentrum Lübeck (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- University Hospital Schleswig-Holstein (DE)
- Heinrich Heine University Düsseldorf (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- European Journal of Surgical Oncology
- Published
- 2025-08-15
- DOI
- https://doi.org/10.1016/j.ejso.2025.110392
- Citations
- 3
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.81